Programmes and partnerships

We know from experience that the barriers to access care are complex: from getting the product to those who need it – at a price they can afford and with a reliability they can depend on, to combatting shortages of healthcare professionals who can effectively diagnose and treat diabetes with the required equipment.

Through a growing range of programmes and partnerships, we continue to expand our efforts and creating solutions to help people access the diabetes care they need, no matter where they live. 

 


Changing Diabetes® in Children
 


 

While limited public health data exists on children with type 1 diabetes, the unbearable truth is that only few live long enough to make it into the registries in many of the world’s poorest countries.

The Changing Diabetes® in Children programme ensures care and life-saving insulin for children with type 1 diabetes in low- and middle-income countries. Working together with Roche, the International Society for Pediatric and Adolescent Diabetes (ISPAD) and the World Diabetes Foundation (WDF), we have established 177 clinics in 14 countries.  Today, Changing Diabetes® in Children is providing medical care and insulin to nearly 20,000 children.

Learn more about Changing Diabetes® in Children

 


Partnering with the Red Cross
 


More than 65 million people – almost 1% of the world’s population – have been forced to flee their homes and communities due to persecution, violence and human rights violations.

In 2018, we established a ground-breaking partnership with the International Committee of the Red Cross , the Danish Red Cross  to tackle the growing need to improve chronic disease treatment. Our joint effort is anchored in a collective vision that all people living in humanitarian crises should have access to the healthcare they need.

Learn about our partnership to improve chronic care in humanitarian crises

 

War zone

The Defeat-NCD Partnership
 


Access to medicine for non communicable diseases

Rapid changes in demographics and economic growth are causing a surge in the number of people impacted by chronic diseases like type 2 diabetes in many of the world’s poorest countries. 

In 2018, the Defeat-NCD Partnership was established to support countries’ efforts to both prevent and treat chronic disease. The public–private–people partnership is hosted by the United Nations Institute for Training and Research (UNITAR) and includes governments, multilateral agencies, civil society, academia, philanthropic foundations and the private sector.

Learn more about the Defeat-NCD Partnership

 


Reaching the base of the pyramid
 


 

Since 2010, we have been taking an innovative approach to improve access to affordable insulin and diabetes care for the working poor in low- and middle-income countries.

For many of these patients, living with diabetes becomes a daily struggle to cover the cost of treatment and basic necessities like housing, food and transportation.

Our Base of the Pyramid programme aims to ease the cost burden related to both medicines and healthcare. Initiated in 2010, the programme is working through local health authorities and health care organisations in four African countries.

Learn more about the Base of the Pyramid programme

 


Novo Nordisk Haemophilia Foundation
 


The Novo Nordisk Haemophilia Foundation (NNHF) is a grant-making, non-profit organisation that strives to improve access to care for people with haemophilia and allied bleeding disorders in developing and emerging countries.

Haemophilia is a hereditary bleeding disorder affecting one in 10,000 people.1 75% of people with haemophilia live in the developing world, where most do not have a diagnosis or access to adequate care.

Learn more about the Novo Nordisk Haemophilia Foundation